A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis
Clinical trial NCT02950155 · COMPLETED
Trial details
- NCT number
- NCT02950155
- Sponsor
- Fredrik Piehl
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-16
- Primary completion
- 2021-01-30
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.